Evaluation of T cell recognition of theileria parva homologs of apicomplexan antigens.
No hay miniatura disponible
Fecha
Autores
Título de la revista
ISSN de la revista
Título del volumen
Editor
University of Nairobi
Resumen
Descripción
East Coast fever is a severe lymphoproliferative disease of cattle caused by the intracellular protozoan Theileriaparva from the family Apicomplexa, CD8+ cytotoxic T lymphocyte (CTL) mediated destruction of parasite infected lymphocytes constitutes the dominant protective immune response following exposure to infection or vaccination using a live infection and treatment protocol. Appropriate delivery of parasite antigens targeted by CTL from T parva immune cattle has long been proposed as a strategy for the development of a subunit vaccine that would contribute substantially to a sustainable integrated ECF control program. Gene homologs encoding antigens from other apicomplexan parasites constitute a source of vaccine candidate antigens. The aim of this study was to evaluate the recognition of T parva homologs of known apicomplexan antigens by CD8+ and CD4+ T lymphocytes isolated from cattle immunized by a live vaccine. Eight T parva homo logs of apicomplexan antigens were sub-cloned into a eukaryotic expression vector and transiently transfected into bovine antigen presenting cells (APC). Recognition of transfected APC by T parva specific CD8+ CTL lines was assessed using an IFN-y ELISpot assay but none of the 7 CTL lines tested recognized any of the homologs. A recombinant protein was generated representing atruncated version of one T parva protein designated X9-3 (a homolog of T Complex Protein-I zeta subunit in Babesia microti) and tested in immunoassays for recognition by T cells from immune cattle. Peripheral blood mononuclear cells from 3112cattle and a T parva specific polyclonal CD4+ T cell line from immune cattle BW014 responded to the X9-3 protein. The results suggest that none of the eight homolog genes are CTL target antigens but X9-3 is a candidate T-helper cell target antigen and should be considered for inclusion in a subunit vaccine against ECF
Palabras clave
theileria, antigens, cells